AtomVie Global Radiopharma Inc.

Private

HamiltonHealthcare & Life Scienceshttps://www.atomvie.com/

Last Round

Series A

Jun 1, 2023

Total Funding Raised

$90M

Company Overview

AtomVie Global Radiopharma Inc. is a pharmaceuticals company operating as a contract development and manufacturing organization (CDMO) for the GMP manufacturing and worldwide distribution of radiopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radiopharmaceutical manufacturingCDMOcontract development and manufacturing organizationradiotherapeuticsradioligand therapyRLTGMP manufacturingradiopharmaceutical logisticstargeted cancer therapypharma supply chainclinical trial supplycommercial supplyprocess developmentregulatory supportdrug product manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AtomVie Global Radiopharma Inc. Comparables

Compare AtomVie Global Radiopharma Inc. with similar companies based on industry and business-model similarity.

AtomVie Global Radiopharma Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nucleus RadioPharma	90%
SpectronRx	84%
NorthStar Medical Radioisotopes, LLC	81%

View all Comparables

AtomVie Global Radiopharma Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Bruno Paquin

Chief Executive Officer

Executive Team

Patrick A. Lim

Chief Financial Officer

Executive Team

Dodi Adar M.Sc.

Chief Operating Officer

Executive Team

AtomVie Global Radiopharma Inc. Investors

Notable investors and investment history

AtomVie Global Radiopharma Inc. investors
Investor	Rounds
Avego Management	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors grew 42% MoM, reaching 1.8K.
May 2, 2025
Monthly visitors increased 145% MoM, reaching 2.1K.

View all signals

AtomVie Global Radiopharma Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AtomVie Global Radiopharma Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AtomVie Global Radiopharma Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHamilton

Employee Range148

Year Founded2021

Last FundingJun 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.